based on 5 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 5 analysts offering long term price targets for Jupiter Life Line Hospitals Ltd. An average target of ₹1611
Source: S&P Global Market Intelligence
Jupiter Life Line Hospitals Ltd price forecast by 5 analysts
Upside of5.92%
High
₹1825
Target
₹1611.00
Low
₹1450
Jupiter Life Line Hospitals Ltd target price ₹1611, a slight upside of 5.92% compared to current price of ₹1520.95. According to 5 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Jupiter Life Line Hospitals Ltd revenue growth forecast
Expected growth rate Q1, FY2026:39.34%
Forecast
Actual
Including amortisation and stock based compensations
Jupiter Life Line Hospitals Ltd EPS growth forecast
EPS estimate Q1, FY2026:44.17%
Forecast
Actual
Source: S&P Global Market Intelligence
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 13.96 % |
3 Month Return | + 15.39 % |
1 Year Return | + 42.85 % |
Market Stats | |
Previous Close | ₹1,542.10 |
Open | ₹1,525.00 |
Volume | 37.87K |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹10,110.94Cr |
P/E Ratio | 54.89 |
PEG Ratio | 5.97 |
Market Cap | ₹10,110.94 Cr |
P/B Ratio | 6.31 |
EPS | 26.94 |
Dividend Yield | 0 |
Sector | Healthcare |
ROE | 17.77 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
BUY | ₹10,110.94 Cr | 8.28% | 0.50 | ₹176 Cr | ₹1,069 Cr | |
NA | ₹78.67 Cr | 37.94% | 0.56 | -₹2 Cr | ₹39 Cr | |
NA | ₹19.28 Cr | 18.02% | 0.60 | ₹4 Cr | ₹13 Cr | |
BUY | ₹5,136.73 Cr | 14.21% | 0.54 | ₹69 Cr | ₹571 Cr | |
BUY | ₹6,530.27 Cr | 65.89% | 0.70 | ₹41 Cr | ₹1,907 Cr |
Organisation | Jupiter Life Line Hospitals Ltd |
Headquarters | |
Industry | Healthcare |
E-voting on shares | Click here to vote |
Key events for Jupiter Life Line Hospitals Ltd
Jupiter Lifeline Hospital reported robust Q2 results with revenue, EBITDA, and PAT up 23%, 23%, and 53% year-on-year. The company is on track for capacity expansions and has a revised target price of Rs 1,740, reflecting positive growth prospects.
Jupiter Life Line Hospitals Reports Strong Q2 Growth - 12 Nov, 2024
Jupiter Life Line Hospitals achieved 20% revenue growth and 39% profit increase in Q2. Expansion plans include new hospitals in Dombivli and Pune, with significant investments planned.
Jupiter Life Reports Strong Q2 and Sales Growth - 11 Nov, 2024
Jupiter Life Line Hospitals shows robust financial performance with significant increases in net sales and profits for both consolidated and standalone results in September 2024. The company also reported a 53% YoY jump in Q2 PAT, reflecting strong operational performance across its hospitals.
Jupiter Life Line Hospitals Reports Q2 Earnings - 08 Nov, 2024
Jupiter Life Line Hospitals Limited announced its earnings results for the second quarter and six months ended September 30, 2024. The company operates multi-specialty hospitals in Thane, Pune, and Indore, offering over 30 specialty treatments and promoting medical tourism through its collaboration with ITC group.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
Revenue is up for the last 2 quarters, 295.5 Cr → 332.02 Cr (in ₹), with an average increase of 11.0% per quarter
Profit Spike
Netprofit is up for the last 2 quarters, 44.61 Cr → 51.51 Cr (in ₹), with an average increase of 13.4% per quarter
Price Rise
In the last 1 month, JLHL stock has moved up by 14.0%
FII Holding Up
Foreign Institutions have increased holdings from 6.06% to 8.84% in Sep 2024 quarter
Promoter Holding Unchanged
Promoters holdings remained unchanged at 40.91% of holdings in Sep 2024 quarter
Retail Holding Down
Retail Investor have decreased holdings from 35.76% to 33.37% in Sep 2024 quarter
MF Holding Down
Mutual Funds have decreased holdings from 12.81% to 12.34% in Sep 2024 quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 40.91% | 0.00 | |
Foreign Institutions | 8.84% | 45.89 | |
Mutual Funds | 12.34% | ||
Retail Investors | 33.37% | ||
Others | 4.53% | 1.56 |
Jupiter Life Line Hospitals Ltd in the last 5 years
Lowest (38.93x)
June 4, 2024
Today (54.89x)
November 22, 2024
Industry (97.12x)
November 22, 2024
Highest (63.18x)
December 19, 2023
Jupiter Life Line Hospitals Ltd’s net profit jumped 52.94% since last year same period to ₹51.51Cr in the Q2 2024-2025. On a quarterly growth basis, Jupiter Life Line Hospitals Ltd has generated 15.47% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2024, Jupiter Life Line Hospitals Ltd has declared dividend of ₹1 - translating a dividend yield of 0.07%.
Read More about DividendsBearish
Neutral
Bullish
Jupiter Life Line Hospitals Ltd is currently in a Bullish trading position according to technical analysis indicators.
Jupiter Life Line Hospitals Ltd (JLHL) share price today is ₹1520.95
Jupiter Life Line Hospitals Ltd is listed on NSE
Jupiter Life Line Hospitals Ltd is listed on BSE
PE Ratio of Jupiter Life Line Hospitals Ltd is 54.89
PE ratio = Jupiter Life Line Hospitals Ltd Market price per share / Jupiter Life Line Hospitals Ltd Earnings per share
Today’s traded volume of Jupiter Life Line Hospitals Ltd(JLHL) is 37.87K.
Today’s market capitalisation of Jupiter Life Line Hospitals Ltd(JLHL) is ₹10110.94Cr.
Jupiter Life Line Hospitals Ltd(JLHL | Price |
---|---|
52 Week High | ₹1653.95 |
52 Week Low | ₹993.15 |
Jupiter Life Line Hospitals Ltd(JLHL) share price is ₹1520.95. It is down -8.04% from its 52 Week High price of ₹1653.95
Jupiter Life Line Hospitals Ltd(JLHL) share price is ₹1520.95. It is up 53.14% from its 52 Week Low price of ₹993.15
Jupiter Life Line Hospitals Ltd(JLHL | Returns |
---|---|
1 Day Returns | -21.15% |
1 Month Returns | 13.96% |
3 Month Returns | 15.39% |
1 Year Returns | 42.85% |